176 related articles for article (PubMed ID: 9636579)
1. Reduced acute rejection and side effects with neoral in liver transplantation.
Tisone G; Vennarecci G; Pisani F; Baiocchi L; Mercadante E; Orlando G; Anselmo A; Casciani CU
Transplant Proc; 1998 Jun; 30(4):1430-1. PubMed ID: 9636579
[No Abstract] [Full Text] [Related]
2. Experience with neoral cyclosporine through the oral route in liver transplantation.
Bilbao I; Lazaro JL; Pou L; Charco R; Hildalgo E; Murio E; Margarit C
Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
[No Abstract] [Full Text] [Related]
3. Neoral without intravenous cyclosporine in liver transplantation.
Hemming AW; Greig PD; Cattral MS; Chung SW; Lilly LB; Aljumah AA; Levy GA
Transplant Proc; 1997; 29(1-2):543. PubMed ID: 9123121
[No Abstract] [Full Text] [Related]
4. Low incidence of acute cellular rejection in liver transplantation with Neoral.
Imventarza O; Lendoire J; Bianco G; Saúl J; Braslavsky G; Trigo P; Cueto G; Duek F; Aziz H
Transplant Proc; 1998 Aug; 30(5):1854. PubMed ID: 9723307
[No Abstract] [Full Text] [Related]
5. Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients.
Cao S; Cox KL; Berquist W; So S; Concepcion W; Monge H; Esquivel CO
Transplant Proc; 1998 Dec; 30(8):4322-4. PubMed ID: 9865373
[No Abstract] [Full Text] [Related]
6. A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral.
Shah MB; Martin JE; Schroeder TJ; First MR
Transplant Proc; 1998 Dec; 30(8):4048-53. PubMed ID: 9865291
[No Abstract] [Full Text] [Related]
7. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P
Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211
[No Abstract] [Full Text] [Related]
8. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
[No Abstract] [Full Text] [Related]
9. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
[No Abstract] [Full Text] [Related]
10. Low incidence of rejection after synchronous pancreas-kidney transplantation with Neoral.
Cattral MS; Hemming AW; Greig PD; Rowsell C; Chari R; Wright E; Donat D; Cole E; Levy GA
Transplant Proc; 1998 Aug; 30(5):1946. PubMed ID: 9723346
[No Abstract] [Full Text] [Related]
11. Neoral versus Sandimmun: clinical impact and modification of immunosuppressive therapy in cardiac transplantation.
Maccherini M; Bernazzali S; Diciolla F; Giunti G; Bizzarri F; Lisi GF; Davoli G; Biagioli B; Giomarelli PP; Simeone F; Caciorgna M; Marchetti L; Pula G; Sani G; Toscano M
Transplant Proc; 1998 Aug; 30(5):1904-5. PubMed ID: 9723327
[No Abstract] [Full Text] [Related]
12. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
Transplant Proc; 1998 Jun; 30(4):1401-2. PubMed ID: 9636566
[TBL] [Abstract][Full Text] [Related]
13. Early use and oral absorption of cyclosporine neoral after liver transplantation.
Kattner A; Ringe B; Haller GW; Kirchner G; Sewing KF; Winkler M
Transplant Proc; 1998 Jun; 30(4):1422-3. PubMed ID: 9636576
[No Abstract] [Full Text] [Related]
14. Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group.
Wiesner RH
Transplant Proc; 1998 Jun; 30(4):1399-400. PubMed ID: 9636565
[No Abstract] [Full Text] [Related]
15. Neoral reduces the incidence of acute rejection after renal transplantation.
Sandrini S; Setti G; Gaggia P; Chiappini R; Maffeis R; Tardanico R; Maiorca R
Transplant Proc; 1998 Aug; 30(5):1758-9. PubMed ID: 9723269
[No Abstract] [Full Text] [Related]
16. Neoral versus Sandimmune in kidney transplantation.
Tisone G; Orlando G; Mercadante E; Vennarecci G; Pisani F; Buonomo O; Negrini S; Casciani CU
Transplant Proc; 1998 Aug; 30(5):1749-50. PubMed ID: 9723265
[No Abstract] [Full Text] [Related]
17. Neoral in liver transplantation.
Jamieson NV; Tan L; Jamieson I; Trull A; Gimson AE; Alexander G; Friend PJ; Calne RY
Transplant Proc; 1996 Aug; 28(4):2229-31. PubMed ID: 8769207
[No Abstract] [Full Text] [Related]
18. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
Levy GA
Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216
[No Abstract] [Full Text] [Related]
19. NOF-11: a one-year randomized double-blind comparison of Neoral versus Sandimmune in pediatric liver transplantation.
Alvarez F; Atkison P; Grant D; Jones A; Kim P; Kneteman N; Laurin L; Martin S; Paradis K; Shapiro J; Smith L; Superina R; Tan A
Transplant Proc; 1998 Aug; 30(5):1961. PubMed ID: 9723352
[No Abstract] [Full Text] [Related]
20. Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group.
Korn A; Färber L; Maibücher A; Buchholz B; Offermann G
Transplant Proc; 1997 Nov; 29(7):2945-7. PubMed ID: 9365623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
